We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

In this section

Shares

Directors' dealings from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Director dealings: Sirius Real Estate CEO snaps up shares

Mon 28 September 2026 14:20

(Sharecast News) - Sirius Real Estate revealed on Monday that chief executive Andrew Coombs had acquired 100,000 ordinary shares in the FTSE 250-listed property firm.

Director dealings: Trufin CEO snaps up more shares

Fri 25 September 2026 12:38

(Sharecast News) - Trufin revealed on Friday that chief executive James van den Bergh had acquired 25,000 ordinary shares in the AIM-listed software firm.

Director dealings: Oxford Biomedica chair ups stake

Thu 24 September 2026 09:19

(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.

Director dealings: Intercede's Dan O'Brien raises stake

Wed 23 September 2026 14:23

(Sharecast News) - Intercede Group revealed on Wednesday that non-executive director Dan O'Brien had acquired 22,070 ordinary shares in the AIM-listed cybersecurity software firm.

Director dealings: Foreterra non-executive director snaps up shares

Tue 22 September 2026 13:29

(Sharecast News) - Forterra revealed on Tuesday that non-executive director Gavin Hill had acquired 28,944 ordinary shares in the London-listed building products manufacturer.

Director dealings: Trufin CEO raises stake

Mon 21 September 2026 12:05

(Sharecast News) - Trufin revealed on Monday that chief executive James van den Bergh had acquired 150,000 ordinary shares in the AIM-listed software firm.

Director dealings: Astrazeneca CEO raises stake

Fri 18 September 2026 14:14

(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.

Director dealings: McBride CFO lowers stake

Thu 17 September 2026 12:11

(Sharecast News) - McBride said on Thursday that chief financial officer Marck Strickland had disposed of 110,000 ordinary shares in the London-listed household goods manufacturer.

Director dealings: Hilton Food CEO snaps up shares

Wed 16 September 2026 14:56

(Sharecast News) - Hilton Food Group revealed on Wednesday that chief executive Mark Allen had acquired 14,500 ordinary shares in the FTSE 250-listed food packaging business.

Director dealings: Kromek chairman raises stake

Tue 15 September 2026 12:53

(Sharecast News) - Kromek Group revealed on Tuesday that chairman Rakesh Sharma had acquired 145,454 ordinary shares in the AIM-listed global detection firm.